Premium
Aspirin and codeine in two postpartum pain models
Author(s) -
Bloomfield Saul S.,
Barden Tom P.,
Mitchell ]Jeanette
Publication year - 1976
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt1976204499
Subject(s) - codeine , episiotomy , medicine , aspirin , placebo , analgesic , anesthesia , morphine , pregnancy , alternative medicine , pathology , biology , genetics
Aspirin and codeine, standard reference analgesics, are frequently used as positive controls in clinical trials of new oral analgesics. In randomized parallel double‐blind studies, single doses of aspirin and codeine were compared with placebo in episiotomy pain (99 patients) and in postpartum uterine pain (130 patients), common models in analgesic trials. With aspirin, 600 and 1,200 mg, in episiotomy pain, analgesia as measured by pain intensity difference (PID) scores began within 1 hr, peaked at the second hour (p < 0.01), and continued to the fifth hour (p < 0.01). In uterine pain, responses with aspirin, 650 mg, were observed to be equally good. With codeine, 60 mg, in episiotomy pain measurable analgesia was present by the second hour and was significant at the fourth hour (p < 0.05); in uterine pain, responses were indistinguishable from placebo throughout an 8‐hr time‐course. Codeine seemed ineffective and therefore unacceptable as a positive control in uterine pain. These data imply that the two postpartum pain models are qualitatively different: episiotomy pain seems sensitive to both aspirin alld codeine, while uterine pain appears sensitive to aspirin but not to codeine.